Results 251 to 260 of about 9,406,168 (354)

TNFR2 signaling in oligodendrocyte precursor cells suppresses their immune-inflammatory function and detrimental microglia activation in CNS demyelinating disease. [PDF]

Brain Behav Immun
Desu HL, Thougaard E, Carney BN, Illiano P, Plastini MJ, Florimon Y, Mini A, Guastucci C, Kang B, Lee JK, Lambertsen KL, Brambilla R.   +11 more
europepmc   +1 more source

Sars-Cov-2 infection related inflammatory and demyelinating disease; a brief case series. [PDF]

Mult Scler Relat Disord, 2021
Kaya Tutar N, Omerhoca S, Coban E, Kale N.   +3 more
europepmc   +1 more source

Is every sharply defined, symmetrical, necrotic-demyelinating lesion in the corpus callosum an actual manifestation of Marchiafava–Bignami disease?

, 2001
József Kollár, Mózes Péter, Béla Fülesdi, Judit Sikula   +3 more
openalex   +2 more sources

Modulating the immune response in demyelinating diseases [PDF]

, 1998
Robert Hughes
openalex   +1 more source

Molecular Biology, Epidemiology, and Pathogenesis of Progressive Multifocal Leukoencephalopathy, the JC Virus-Induced Demyelinating Disease of the Human Brain

Clinical Microbiology Reviews, 2012
Michael W. Ferenczy, L. Marshall, C. Nelson, W. Atwood, A. Nath, K. Khalili, E. Major   +6 more
semanticscholar   +1 more source

Evaluation of ASC as a therapeutic target for Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 1, January 2026.
Abstract Neuroinflammation is increasingly recognized as a central contributor to the pathogenesis and progression of Alzheimer's disease (AD). The apoptosis‐associated speck‐like protein containing a CARD (ASC), encoded by the PYCARD gene, plays a critical role in the formation of multiple inflammasomes, including NLRP3, a key mediator of inflammation
W. Brent Clayton, Joshua A. Kulas, Jiahui Liu, Nidhi Walia, Claudia Rangel‐Barajas, Travis Johnson, Jie Zhang, Kun Huang, Andrew D. Mesecar, Jeffrey L. Dage, Bruce T. Lamb, Alan D. Palkowitz, Timothy I. Richardson   +12 more
wiley   +1 more source

Fulminant demyelinating disease of the central nervous system effectively treated with a combination of decompressive craniectomy and immunotherapy: A case report and literature review. [PDF]

Clin Case Rep
Ide T, Ebashi R, Eriguchi M, Aishima S, Abe T, Hara H.   +5 more
europepmc   +1 more source

Biomarkers in Rare Demyelinating Disease of the Central Nervous System. [PDF]

Int J Mol Sci, 2020
Boziki M, Sintila SA, Ioannidis P, Grigoriadis N.   +3 more
europepmc   +1 more source

Secukinumab Treatment in Patients with Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome

, 2022
Rossana Scrivo, Andrea Picchianti Diamanti, Maria Sole Chimenti, Emanuele Molteni, Giorgio Sciarra, Federico Bari, E. Greco, Alberto Bergamini, Bruno Laganà, Fabrizio Conti   +9 more
openalex   +1 more source

Genetic Association Between Polymyositis/Dermatomyositis and Epilepsy: Insights From Mendelian Randomization and Bioinformatic Analyses

Brain and Behavior, Volume 16, Issue 1, January 2026.
This Mendelian randomization study provides robust evidence for a causal link between polymyositis (PM) and epilepsy, highlighting the role of immune‐mediated mechanisms in epilepsy development, while no such association was found for dermatomyositis (DM). Through bioinformatic and statistical analyses, key genes and pathways were identified, with IER3,
Ying Liu, Yuhang Yu, Chulong Fang, Qingzhong Wu, Lingli Ou, Jianhao Xiao, Kui Duan, Ting Jiang, Lan Ye, Xiao Hu, Zhanhui Feng   +10 more
wiley   +1 more source